Torrent Expands Recall for Losartan Tablets, FDA Says

Torrent Pharmaceuticals expands its voluntary recall for Losartan Potassium Tablets UPS and Losartan Potassium/hydrochlorothiazide tablets, USP.

• Recall is expanded to include an additional 36 lots of Losartan potassium Tablets USP and 68 lots of Losartan Potassium/Hydrochlorothiazide Tablets, USP
• Torrent hasn’t received any reports of adverse events related to the recall, FDA says
• Statement

©2019 Bloomberg L.P. All rights reserved. Used with permission